NeoStrep Project Partners Work Packages News Funding

NeoStrep

Development of Group B Streptococcal vaccine

NeoStrep is funded by the European Commission FP7 Programme HEALTH


CONTACT ¦   

NeoStrep_Partner_Forum


MinervaX is a biotech company established in 2010 to commercialize inventions relating to the GBS-NN vaccine candidate.




www.minervax.com